Franchise Cannabis Corp. completes reverse take-over of Franchise Global Health Inc.

2 minute read
25 March 2022

On March 25, 2022, Franchise Global Health Inc. (formerly capital pool company Mercury Acquisitions Corp.) ("Franchise Global") (TSXV: FGH, formerly traded as MERC.P) announced that it had completed its previously announced business combination with Franchise Cannabis Corp. ("Franchise"), resulting in a reverse take-over of Franchise Global, which transaction constituted Franchise Global's "Qualifying Transaction" within the meaning of Policy 2.4 - Capital Pool Companies of the TSX Venture Exchange.

Franchise Global, through its subsidiaries, is a multi-national operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally. Franchise Global's business objective is to develop a fully-integrated, leading European medical cannabis business, with the goal of providing high-quality pharmaceutical grade medical cannabis to distribution partners and, ultimately, to patients, at competitive prices.

Gowling WLG advised Franchise with respect to this transaction with a team that included Peter Simeon, Jacob Cawker, Nav Pannu, Sean Walsh and Blair Somerville, and assisted by student-at-law Jevaughn Johnson.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.